Animal models of cystic fibrosis in the era of highly effective modulator therapies

Ratjen, 2015, Cystic fibrosis, Nat Rev Dis Prim, 1, 15010, 10.1038/nrdp.2015.10 Bose, 2015, Exploiting species differences to understand the CFTR Cl- channel, Biochem Soc Trans, 43, 975, 10.1042/BST20150129 Cui, 2019, An ancient CFTR ortholog informs molecular evolution in ABC transporters, Dev Cell, 51, 421, 10.1016/j.devcel.2019.09.017 Wilke, 2011, Mouse models of cystic fibrosis: phenotypic analysis and research applications, J Cyst Fibros, 10, S152, 10.1016/S1569-1993(11)60020-9 Guilbault, 2007, Cystic fibrosis mouse models, Am J Respir Cell Mol Biol, 36, 1, 10.1165/rcmb.2006-0184TR Rogers, 2008, Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs, Science, 321, 1837, 10.1126/science.1163600 Bouzek, 2021, Early lung disease exhibits bacteria-dependent and -independent abnormalities in cystic fibrosis pigs, Am J Respir Crit Care Med, 204, 692, 10.1164/rccm.202102-0451OC Ostedgaard, 2011, The DeltaF508 mutation causes CFTR misprocessing and cystic fibrosis-like disease in pigs, Sci Transl Med, 3, 10.1126/scitranslmed.3001868 Stoltz, 2013, Intestinal CFTR expression alleviates meconium ileus in cystic fibrosis pigs, J Clin Invest, 123, 2685, 10.1172/JCI68867 Thurman, 2022, A single-cell atlas of large and small airways at birth in a porcine model of cystic fibrosis, Am J Respir Cell Mol Biol, 10.1165/rcmb.2021-0499OC Sun, 2010, Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis, J Clin Invest, 120, 3149, 10.1172/JCI43052 Sun, 2019, In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis, Sci Transl Med, 11, 10.1126/scitranslmed.aau7531 Tuggle, 2014, Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats, PLoS One, 9, 10.1371/journal.pone.0091253 Birket, 2018, Development of an airway mucus defect in the cystic fibrosis rat, JCI Insight, 3, 10.1172/jci.insight.97199 Sharma, 2020, A novel G542X CFTR rat model of cystic fibrosis is sensitive to nonsense mediated decay, Front Physiol, 11, 611294, 10.3389/fphys.2020.611294 McCarron, 2020, Phenotypic characterization and comparison of cystic fibrosis rat models generated using CRISPR/Cas9 gene editing, Am J Pathol, 190, 977, 10.1016/j.ajpath.2020.01.009 Dreano, 2019, Characterization of two rat models of cystic fibrosis-KO and F508del CFTR-Generated by Crispr-Cas9, Animal Model Exp Med, 2, 297, 10.1002/ame2.12091 Navis, 2015, Loss of cftr function leads to pancreatic destruction in larval zebrafish, Dev Biol, 399, 237, 10.1016/j.ydbio.2014.12.034 Cafora, 2019, Phage therapy against Pseudomonas aeruginosa infections in a cystic fibrosis zebrafish model, Sci Rep, 9, 1527, 10.1038/s41598-018-37636-x Fan, 2018, A sheep model of cystic fibrosis generated by CRISPR/Cas9 disruption of the CFTR gene, JCI Insight, 3, 10.1172/jci.insight.123529 Viotti Perisse, 2021, Sheep models of F508del and G542X cystic fibrosis mutations show cellular responses to human therapeutics, FASEB Bioadv, 3, 841, 10.1096/fba.2021-00043 Kim, 2020, Drosophila as a model for studying cystic fibrosis pathophysiology of the gastrointestinal system, Proc Natl Acad Sci USA, 117, 10357, 10.1073/pnas.1913127117 Xu, 2021, Phenotypes of CF rabbits generated by CRISPR/Cas9-mediated disruption of the CFTR gene, JCI Insight, 6, 10.1172/jci.insight.139813 Yang, 2020, Production of CFTR-DeltaF508 rabbits, Front Genet, 11, 627666, 10.3389/fgene.2020.627666 Mall, 2004, Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice, Nat Med, 10, 487, 10.1038/nm1028 Livraghi-Butrico, 2012, Genetically determined heterogeneity of lung disease in a mouse model of airway mucus obstruction, Physiol Genom, 44, 470, 10.1152/physiolgenomics.00185.2011 Livraghi-Butrico, 2012, Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation, Mucosal Immunol, 5, 397, 10.1038/mi.2012.17 Terryah, 2018, Evaluation of a SPLUNC1-derived peptide for the treatment of cystic fibrosis lung disease, Am J Physiol Lung Cell Mol Physiol, 314, L192, 10.1152/ajplung.00546.2016 Sabater, 2019, Whole body periodic acceleration in normal and reduced mucociliary clearance of conscious sheep, PLoS One, 14, 10.1371/journal.pone.0224764 Nickolaus, 2020, Preclinical evaluation of the epithelial sodium channel inhibitor BI 1265162 for treatment of cystic fibrosis, ERJ Open Res, 6, 10.1183/23120541.00429-2020 Kim, 2020, Losartan rescues inflammation-related mucociliary dysfunction in relevant models of cystic fibrosis, Am J Respir Crit Care Med, 201, 313, 10.1164/rccm.201905-0990OC Fernandez-Blanco, 2018, Attached stratified mucus separates bacteria from the epithelial cells in COPD lungs, JCI Insight, 3, 10.1172/jci.insight.120994 Voynow, 2004, Neutrophil elastase induces mucus cell metaplasia in mouse lung, Am J Physiol Lung Cell Mol Physiol, 287, L1293, 10.1152/ajplung.00140.2004 Dubaissi, 2020, A 'tad' of hope in the fight against airway disease, Biochem Soc Trans, 48, 2347, 10.1042/BST20200745 Lopez, 2021, Developing tadpole Xenopus laevis as a comparative animal model to study Mycobacterium abscessus pathogenicity, Int J Mol Sci, 22, 10.3390/ijms22020806 Keiser, 2011, New animal models of cystic fibrosis: what are they teaching us?, Curr Opin Pulm Med, 17, 478, 10.1097/MCP.0b013e32834b14c9 Semaniakou, 2018, Animal models in the pathophysiology of cystic fibrosis, Front Pharmacol, 9, 1475, 10.3389/fphar.2018.01475 McCarron, 2021, Animal and cell culture models for cystic fibrosis: which model is right for your application?, Am J Pathol, 191, 228, 10.1016/j.ajpath.2020.10.017 McCarron, 2018, Airway disease phenotypes in animal models of cystic fibrosis, Respir Res, 19, 54, 10.1186/s12931-018-0750-y Rosen, 2018, Animal and model systems for studying cystic fibrosis, J Cyst Fibros, 17, S28, 10.1016/j.jcf.2017.09.001 Heijerman, 2019, Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial, Lancet (London, England), 394, 1940, 10.1016/S0140-6736(19)32597-8 Middleton, 2019, Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele, N Engl J Med, 381, 1809, 10.1056/NEJMoa1908639 Middleton, 2021, Development of elexacaftor - tezacaftor - ivacaftor: highly effective CFTR modulation for the majority of people with Cystic Fibrosis, Expet Rev Respir Med, 15, 723, 10.1080/17476348.2021.1855980 Nichols, 2021, PROMISE: working with the CF community to understand emerging clinical and research needs for those treated with highly effective CFTR modulator therapy, J Cyst Fibros, 20, 205, 10.1016/j.jcf.2021.02.003 Lore, 2020, Collaborative cross mice yield genetic modifiers for Pseudomonas aeruginosa infection in human lung disease, mBio, 11, 10.1128/mBio.00097-20 Meeker, 2020, CFTR dysregulation drives active selection of the gut microbiome, PLoS Pathog, 16, 10.1371/journal.ppat.1008251 Pashuck, 2009, Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation, Pediatr Res, 65, 311, 10.1203/PDR.0b013e3181961e80 Durie, 2004, Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model, Am J Pathol, 164, 1481, 10.1016/S0002-9440(10)63234-8 Geiser, 2014, Biokinetics of nanoparticles and susceptibility to particulate exposure in a murine model of cystic fibrosis, Part Fibre Toxicol, 11, 19, 10.1186/1743-8977-11-19 Tang, 2020, Viral vectors, animal models, and cellular targets for gene therapy of cystic fibrosis lung disease, Hum Gene Ther, 31, 524, 10.1089/hum.2020.013 Ensinck, 2021, On the corner of models and cure: gene editing in cystic fibrosis, Front Pharmacol, 12, 662110, 10.3389/fphar.2021.662110 Tang, 2020, Repeat dosing of AAV2.5T to ferret lungs elicits an antibody response that diminishes transduction in an age-dependent manner, Mol Ther Methods Clin Dev, 19, 186, 10.1016/j.omtm.2020.09.008 Farrow, 2021, Towards human translation of lentiviral airway gene delivery for cystic fibrosis: a one-month CFTR and reporter gene study in marmosets, Hum Gene Ther, 32, 806, 10.1089/hum.2020.267 Cooney, 2020, Intratracheal aerosolization of viral vectors to newborn pig airways, Biotechniques, 68, 235, 10.2144/btn-2019-0150 Haque, 2018, Chemically modified hCFTR mRNAs recuperate lung function in a mouse model of cystic fibrosis, Sci Rep, 8, 16776, 10.1038/s41598-018-34960-0 Reyne, 2021, Single-dose lentiviral mediated gene therapy recovers CFTR function in cystic fibrosis knockout rats, Front Pharmacol, 12, 682299, 10.3389/fphar.2021.682299 Cooney, 2019, A novel AAV-mediated gene delivery system corrects CFTR function in pigs, Am J Respir Cell Mol Biol, 61, 747, 10.1165/rcmb.2019-0006OC Kim, 2016, Barriers to inhaled gene therapy of obstructive lung diseases: a review, J Contr Release, 240, 465, 10.1016/j.jconrel.2016.05.031 Brinks, 2019, The cystic fibrosis-like airway surface layer is not a significant barrier for delivery of eluforsen to airway epithelial cells, J Aerosol Med Pulm Drug Deliv, 32, 303, 10.1089/jamp.2018.1502 Farrow, 2018, Epithelial disruption: a new paradigm enabling human airway stem cell transplantation, Stem Cell Res Ther, 9, 153, 10.1186/s13287-018-0911-4 Allan, 2021, Treatment of cystic fibrosis: from gene- to cell-based therapies, Front Pharmacol, 12, 639475, 10.3389/fphar.2021.639475 McHugh, 2018, A G542X cystic fibrosis mouse model for examining nonsense mutation directed therapies, PLoS One, 13, 10.1371/journal.pone.0199573 Gawenis, 2019, A BAC transgene expressing human CFTR under control of its regulatory elements rescues cftr knockout mice, Sci Rep, 9, 11828, 10.1038/s41598-019-48105-4 Cho, 2021, Ivacaftor restores delayed mucociliary transport caused by Pseudomonas aeruginosa-induced acquired cystic fibrosis transmembrane conductance regulator dysfunction in rabbit nasal epithelia, Int Forum Allergy Rhinol Birket, 2020, Ivacaftor reverses airway mucus abnormalities in a rat model harboring a humanized g551d-CFTR, Am J Respir Crit Care Med, 202, 1271, 10.1164/rccm.202002-0369OC Green, 2021, Ivacaftor partially corrects airway inflammation in a humanized G551D rat, Am J Physiol Lung Cell Mol Physiol, 320, L1093, 10.1152/ajplung.00082.2021 Meyerholz, 2018, Lack of cystic fibrosis transmembrane conductance regulator disrupts fetal airway development in pigs, Lab Invest, 98, 825, 10.1038/s41374-018-0026-7 Bonvin, 2008, Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice, J Physiol, 586, 3231, 10.1113/jphysiol.2008.150763 Chang, 2012, Sinus hypoplasia precedes sinus infection in a porcine model of cystic fibrosis, Laryngoscope, 122, 1898, 10.1002/lary.23392 Plyler, 2019, Non-obstructive vas deferens and epididymis loss in cystic fibrosis rats, Mech Dev, 155, 15, 10.1016/j.mod.2018.10.002 Pierucci-Alves, 2011, Swine models of cystic fibrosis reveal male reproductive tract phenotype at birth, Biol Reprod, 85, 442, 10.1095/biolreprod.111.090860 Boucher, 2019, Muco-obstructive lung diseases, N Engl J Med, 380, 1941, 10.1056/NEJMra1813799 Wine, 2018, Progress in understanding mucus abnormalities in cystic fibrosis airways, J Cyst Fibros, 17, S35, 10.1016/j.jcf.2017.09.003 Hansson, 2019, Mucus and mucins in diseases of the intestinal and respiratory tracts, J Intern Med, 285, 479, 10.1111/joim.12910 Morrison, 2019, Mucus, mucins, and cystic fibrosis, Pediatr Pulmonol, 54, S84 Esther, 2019, Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis, Sci Transl Med, 11, 10.1126/scitranslmed.aav3488 Xie, 2018, Mucociliary transport in healthy and cystic fibrosis pig airways, Ann Am Thoracic Soc, 15, S171, 10.1513/AnnalsATS.201805-308AW Rosen, 2018, Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets, Am J Respir Crit Care Med, 197, 1308, 10.1164/rccm.201708-1616OC Choi, 2000, A comparative study of mammalian tracheal mucous glands, J Anat, 197, 361 Tiddens, 2014, What did we learn from two decades of chest computed tomography in cystic fibrosis?, Pediatr Radiol, 44, 1490, 10.1007/s00247-014-2964-6 Yu, 2022, Cellular and molecular architecture of submucosal glands in wild-type and cystic fibrosis pigs, Proc Natl Acad Sci USA, 119, 10.1073/pnas.2119759119 Fernandez-Petty, 2019, A glycopolymer improves vascoelasticity and mucociliary transport of abnormal cystic fibrosis mucus, JCI Insight, 4, 10.1172/jci.insight.125954 Pieper, 2020, Intravital microscopic optical coherence tomography imaging to assess mucus-mobilizing interventions for muco-obstructive lung disease in mice, Am J Physiol Lung Cell Mol Physiol, 318, L518, 10.1152/ajplung.00287.2019 Keiser, 2015, Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs, Am J Respir Cell Mol Biol, 52, 683, 10.1165/rcmb.2014-0250OC Rogers, 2018, Mucociliary clearance in mice measured by tracking trans-tracheal fluorescence of nasally aerosolized beads, Sci Rep, 8, 14744, 10.1038/s41598-018-33053-2 Wielputz, 2011, In vivo monitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography, Eur Respir J, 38, 1060, 10.1183/09031936.00149810 Stahr, 2016, Quantification of heterogeneity in lung disease with image-based pulmonary function testing, Sci Rep, 6, 29438, 10.1038/srep29438 Murrie, 2020, Real-time in vivo imaging of regional lung function in a mouse model of cystic fibrosis on a laboratory X-ray source, Sci Rep, 10, 447, 10.1038/s41598-019-57376-w Ehre, 2019, An improved inhaled mucolytic to treat airway muco-obstructive diseases, Am J Respir Crit Care Med, 199, 171, 10.1164/rccm.201802-0245OC Graeber, 2013, Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease, Am J Respir Cell Mol Biol, 49, 410, 10.1165/rcmb.2013-0050OC Zhou, 2008, Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice, Am J Respir Crit Care Med, 178, 1245, 10.1164/rccm.200803-442OC Sun, 2014, Lung phenotype of juvenile and adult cystic fibrosis transmembrane conductance regulator-knockout ferrets, Am J Respir Cell Mol Biol, 50, 502, 10.1165/rcmb.2013-0261OC Stoltz, 2010, Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth, Sci Transl Med, 2, 29ra31, 10.1126/scitranslmed.3000928 Darrah, 2017, Cystic fibrosis mice develop spontaneous chronic Bordetella airway infections, J Infect Pulm Dis, 3 Kukavica-Ibrulj, 2008, Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies, Lab Anim, 42, 389, 10.1258/la.2007.06014e Cigana, 2020, Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa, Eur Respir J, 55, 10.1183/13993003.02456-2018 Chen, 2021, Novel lytic phages protect cells and mice against Pseudomonas aeruginosa infection, J Virol, 10.1128/JVI.01832-20 Kirby, 2019, Efficacy of aerosolized rifaximin versus tobramycin for treatment of Pseudomonas aeruginosa pneumonia in mice, Antimicrob Agents Chemother, 63, 10.1128/AAC.02341-18 Pont, 2021, Zebrafish embryo infection model to investigate Pseudomonas aeruginosa interaction with innate immunity and validate new therapeutics, Front Cell Infect Microbiol, 11, 745851, 10.3389/fcimb.2021.745851 Kiedrowski, 2018, Viral-bacterial Co-infections in the cystic fibrosis respiratory tract, Front Immunol, 9, 3067, 10.3389/fimmu.2018.03067 Degiacomi, 2019, Mycobacterium abscessus, an emerging and worrisome pathogen among cystic fibrosis patients, Int J Mol Sci, 20, 10.3390/ijms20235868 Riva, 2020, A new model of chronic Mycobacterium abscessus lung infection in immunocompetent mice, Int J Mol Sci, 21, 10.3390/ijms21186590 Perrem, 2019, Anti-inflammatories and mucociliary clearance therapies in the age of CFTR modulators, Pediatr Pulmonol, 54, S46 Laucirica, 2020, Progress in model systems of cystic fibrosis mucosal inflammation to understand aberrant neutrophil activity, Front Immunol, 11, 595, 10.3389/fimmu.2020.00595 Bruscia, 2016, Cystic fibrosis lung immunity: the role of the macrophage, J Innate Immun, 8, 550 Paroni, 2013, Response of CFTR-deficient mice to long-term chronic Pseudomonas aeruginosa infection and PTX3 therapy, J Infect Dis, 208, 130, 10.1093/infdis/jis636 Litman, 2021, Serum inflammatory profiles in cystic fibrosis mice with and without Bordetella pseudohinzii infection, Sci Rep, 11, 17535, 10.1038/s41598-021-97033-9 Bruscia, 2016, Increased susceptibility of Cftr-/- mice to LPS-induced lung remodeling, Am J Physiol Lung Cell Mol Physiol, 310, L711, 10.1152/ajplung.00284.2015 van Heeckeren, 2021, Enhancing cystic fibrosis immune regulation, Front Pharmacol, 12, 573065, 10.3389/fphar.2021.573065 Hey, 2021, Epigenetic reprogramming of airway macrophages promotes polarization and inflammation in muco-obstructive lung disease, Nat Commun, 12, 6520, 10.1038/s41467-021-26777-9 Schupp, 2020, Single-cell transcriptional archetypes of airway inflammation in cystic fibrosis, Am J Respir Crit Care Med, 202, 1419, 10.1164/rccm.202004-0991OC Sathe, 2019, Is meconium ileus associated with worse outcomes in cystic fibrosis?, J Cyst Fibros, 18, 746, 10.1016/j.jcf.2019.10.003 S, 2021, Luminal gastrointestinal manifestations of cystic fibrosis, Curr Gastroenterol Rep, 23, 4, 10.1007/s11894-021-00806-5 Olivier, 2015, Animal models of gastrointestinal and liver diseases. Animal models of cystic fibrosis: gastrointestinal, pancreatic, and hepatobiliary disease and pathophysiology, Am J Physiol Gastrointest Liver Physiol, 308, G459, 10.1152/ajpgi.00146.2014 Gibson-Corley, 2021, Animal models and their role in understanding the pathophysiology of cystic fibrosis-associated gastrointestinal lesions, Annu Rev Pathol, 16, 51, 10.1146/annurev-pathol-022420-105133 Grubb, 1997, Intestinal physiology and pathology in gene-targeted mouse models of cystic fibrosis, Am J Physiol, 273, G258 Bodewes, 2015, Altered intestinal bile salt biotransformation in a cystic fibrosis (Cftr-/-) mouse model with hepato-biliary pathology, J Cyst Fibros, 14, 440, 10.1016/j.jcf.2014.12.010 Lord, 2018, Consuming genistein improves survival rates in the absence of laxative in DeltaF508-CF female mice, Nutrients, 10, 10.3390/nu10101418 Sun, 2014, Gastrointestinal pathology in juvenile and adult CFTR-knockout ferrets, Am J Pathol, 184, 1309, 10.1016/j.ajpath.2014.01.035 Vitko, 2016, A novel guluronate oligomer improves intestinal transit and survival in cystic fibrosis mice, J Cyst Fibros, 15, 745, 10.1016/j.jcf.2016.06.005 Hodges, 2011, Cystic fibrosis growth retardation is not correlated with loss of Cftr in the intestinal epithelium, Am J Physiol Gastrointest Liver Physiol, 301, G528, 10.1152/ajpgi.00052.2011 Ballard, 2016, Pathophysiologic evaluation of the transgenic cftr "Gut-Corrected" porcine model of cystic fibrosis, Am J Physiol Lung Cell Mol Physiol, 311, L779, 10.1152/ajplung.00242.2016 Zarei, 2021, Early intrahepatic duct defects in a cystic fibrosis porcine model, Phys Rep, 9 Zarei, 2020, Early pathogenesis of cystic fibrosis gallbladder disease in a porcine model, Lab Invest, 100, 1388, 10.1038/s41374-020-0474-8 Rotti, 2018, Pancreatic and islet remodeling in cystic fibrosis transmembrane conductance regulator (CFTR) knockout ferrets, Am J Pathol, 188, 876, 10.1016/j.ajpath.2017.12.015 Karb, 2021, The intestinal microbiome and cystic fibrosis transmembrane conductance regulator modulators: emerging themes in the management of gastrointestinal manifestations of cystic fibrosis, Curr Gastroenterol Rep, 23, 17, 10.1007/s11894-021-00817-2 Scott, 2020, Cystic fibrosis, CFTR, and colorectal cancer, Int J Mol Sci, 21, 10.3390/ijms21082891 Norkina, 2004, Bacterial overgrowth in the cystic fibrosis transmembrane conductance regulator null mouse small intestine, Infect Immun, 72, 6040, 10.1128/IAI.72.10.6040-6049.2004 Canale-Zambrano, 2010, Toll-like receptor-4 genotype influences the survival of cystic fibrosis mice, Am J Physiol Gastrointest Liver Physiol, 299, G381, 10.1152/ajpgi.00003.2010 Liang, 2021, Intestinal dysbiosis in young cystic fibrosis rabbits, J Personalized Med, 11 Kim, 2017, miR-263a regulates ENaC to maintain osmotic and intestinal stem cell homeostasis in Drosophila, Dev Cell, 40, 23, 10.1016/j.devcel.2016.11.023 Raredon, 2019, Single-cell connectomic analysis of adult mammalian lungs, Sci Adv, 5, 10.1126/sciadv.aaw3851